The association of specific HLA-DQ alleles with autoimmunity is correl
ated with discrete polymorphisms in the HLA-DQ sequence that are local
ized within sites suitable for peptide recognition. The polymorphism a
t residue 57 of the DQB1 polypeptide is of particular interest since i
t may play a major structural role in the formation of a salt bridge s
tructure at one end of the peptide-binding cleft of the DQ molecules.
This polymorphism at residue 57 is a recurrent feature of HLA-DQ evolu
tion, occurring in multiple distinct allelic families, which implies a
functional selection for maintaining variation at this position in th
e class II molecule. We directly tested the amino acid polymorphism at
this site as a determinant for peptide binding and for antigen-specif
ic T cell stimulation. We found that a single Ala-->Asp amino acid 57
substitution in an HLA-DQ3.2 molecule regulated binding of an HSV-2 VP
-16-derived peptide. A complementary single-residue substitution in th
e peptide abolished its binding to DQ3.2 and converted it to a peptide
that can bind to DQ3.1 and DQ3.3 Asp-57-positive MHC molecules. These
binding studies were paralleled by specific T cell recognition of the
class II-peptide complex, in which the substituted peptide abolished
T cell reactivity, which was directed to the DQ3.2-peptide complex, wh
ereas the same T cell clone recognized the substituted peptide present
ed by DQ3.3, a class II restriction element differing from DQ3.2 only
at residue 57. This structural and functional complementarity for resi
due 57 and a specific peptide residue identifies this interaction as a
key controlling determinant of restricted recognition in HLA-DQ-speci
fic immune responses.